Skip to content

Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Pain Control

Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Pain Control

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04399707
Enrollment
180
Registered
2020-05-22
Start date
2020-01-29
Completion date
2021-05-31
Last updated
2020-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Cesarean Section, Transcutaneous Electric Nerve Stimulation

Keywords

TENS, Transcutaneous electric nerve stimulation, Cesarean analgesia

Brief summary

Purpose of study is to evaluate the efficacy of transcutaneous electrical nerve stimulation (TENS) for post-operative pain control after a cesarean delivery compared to placebo and no TENS.

Interventions

Patients will be randomized to active TENS unit, placebo TENS unit, or no TENS unit

DEVICEPlacebo transcutaneous electrical nerve stimulation (TENS) unit

Patients will be randomized to active TENS unit, placebo TENS unit, or no TENS unit

Sponsors

Hawaii Pacific Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Participants are randomized to one of three groups in parallel for the duration of the study

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

\- Women undergoing scheduled or non-urgent cesarean section

Exclusion criteria

* Non-English speaking * Subjects with a history of chronic pain or chronic opioid use * Pre-operative use of opioids for more than 1 week in the preceding 6 months * Previous exposure to the TENS unit * Women with an allergy or contraindication to narcotics/NSAIDs/acetaminophen * Subjects who had a midline vertical skin incision during this operation * Subjects who did not receive intrathecal opioids at the time of their cesarean delivery * Adhesive allergies * Subjects with a pacemaker (due to the unknown effects of the TENS on the electrical activity of the heart) * Intraoperative general anesthesia * Inability to consent to the study * Postpartum tubal ligation

Design outcomes

Primary

MeasureTime frameDescription
Post-operative narcotic consumptionFirst 60 hours post-operativelyTotal postoperative narcotic consumption (measured in morphine equivalents)

Secondary

MeasureTime frameDescription
Duration of hospitalizationFrom date of cesarean delivery until discharge from hospital, assessed up to 1 monthLength of stay in hospital
Pain assessed by numeric analog scale (NAS) (0-10; 0: no pain at all, 10: worst imaginable pain)On post-operative days 1, 2, 3, and day of discharge, assessed up to 1 monthPain scoring
Satisfaction with pain control assessed by NAS (0-10; 0: very dissatisfied, 10: very satisfied)On post-operative days 1, 2, 3, and day of discharge, assessed up to 1 monthPain control satisfaction
Adverse reactions to TENS unitFrom date of randomization until date of discharge, assessed up to 1 monthAdverse reactions to TENS unit

Countries

United States

Contacts

Primary ContactNicole Kurata
nkurata@hawaii.edu(808)577-3344
Backup ContactKelly Yamasato
kyamasat@hawaii.edu

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026